AI-Driven Drug Development Initiative Announced by Corel

Corel Pharmaceuticals is integrating artificial intelligence into its drug discovery pipeline to accelerate research timelines, enhance predictive analysis, and identify promising compounds faster while maintaining scientific accuracy and regulatory integrity.